| Wendy Ledesma, PA | |
|
3772 Satellite Blvd Ste 204, Duluth, GA 30096-5681 | |
| (470) 885-8080 | |
| (470) 885-8088 |
| Full Name | Wendy Ledesma |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant - Medical |
| Location | 3772 Satellite Blvd Ste 204, Duluth, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043423510 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 6387 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wendy Ledesma, PA 3772 Satellite Blvd Ste 204, Duluth, GA 30096-5681 Ph: (470) 885-8080 | Wendy Ledesma, PA 3772 Satellite Blvd Ste 204, Duluth, GA 30096-5681 Ph: (470) 885-8080 |
News Archive
Researchers at Fox Chase Cancer Center have developed a new technique to speed discovery of drug targets in chemical genetics. Fox Chase researcher Jeffrey R. Peterson, Ph.D., and his colleagues describe a new way to swiftly find the proteins targeted by small molecule inhibitors during high-throughput screening (HTS) experiments. The new work offers a critical solution to a common stumbling block in this booming field of drug discovery.
The Senate Finance Committee is scheduled to hold a long-overdue vote on Tuesday on President Obama's nominee to lead the embattled agency responsible for overseeing Medicare, Medicaid and the implementation of health care reforms.
Efforts focused on increasing the use of screening mammography among targeted groups of women should be made a top priority to achieve the largest reduction in late-stage breast cancers, according to the authors of a new study in the October 20 issue of the Journal of the National Cancer Institute.
Four new pre-clinical drug development projects at the National Institutes of Health will target a form of blindness and diseases characterized by cardiac problems. The projects were selected for their potential to treat specific rare diseases and to help scientists uncover new information that can be shared with other researchers.
Pharmacyclics, Inc. today announced the initiation of PCYC-1136-CA, a multi-center study that will investigate the use of ibrutinib (IMBRUVICA®) in combination with MEDI4736, an investigational anti-PD-L1 immune checkpoint inhibitor being developed by AstraZeneca.
› Verified 1 days ago
Austin Douglas Smith, Physician Assistant Medicare: Medicare Enrolled Practice Location: 3023 Shinnecock Hills Dr, Duluth, GA 30097 Phone: 678-764-5824 | |
Donna L Crawford, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 3855 Pleasant Hill Rd, Suite 420, Duluth, GA 30096 Phone: 770-495-1955 Fax: 770-232-9961 | |
Anna Leigh Vonck, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 6300 Hospital Pkwy Ste 100, Duluth, GA 30097 Phone: 707-716-5917 | |
Danielle Jackson, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1845 Satellite Blvd Nw, Duluth, GA 30097 Phone: 404-778-5220 | |
Wossen Adinew Asfaw, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3575 Koger Blvd Ste 116, Duluth, GA 30096 Phone: 770-923-4433 | |
Miriam Abouelnasr Gomes, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3650 Steve Reynolds Blvd, Duluth, GA 30096 Phone: 404-365-0966 |